{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:24:34Z","timestamp":1780374274952,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008556","name":"Paul MacKall and Evanina Bell MacKall Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ymthe.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T19:43:46Z","timestamp":1521661426000},"page":"1581-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness"],"prefix":"10.1016","volume":"26","author":[{"given":"Ji Yun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puya","family":"Aravand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Nikonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfranco","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkady","family":"Lyubarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette L.","family":"Bennicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Shpylchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Commins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke I.","family":"den Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans P.M.","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Koenekoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Roepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patsy","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-shuang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas S.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.03.015_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.03.015_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0076-6879(00)16758-8","article-title":"Genetic analysis of RPE65: from human disease to mouse model","volume":"316","author":"Redmond","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2018.03.015_bib3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.03.015_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.03.015_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2018.03.015_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2018.03.015_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/hum.2010.047","article-title":"Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel","volume":"21","author":"Banin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.03.015_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","article-title":"Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood-onset retinal dystrophy","volume":"123","author":"Weleber","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2018.03.015_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.03.015_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ng2066","article-title":"Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis","volume":"39","author":"den Hollander","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.03.015_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/humu.9513","article-title":"Mutations in LCA5 are an uncommon cause of Leber congenital amaurosis (LCA) type II","volume":"28","author":"Gerber","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2018.03.015_bib12","doi-asserted-by":"crossref","first-page":"24357","DOI":"10.1038\/srep24357","article-title":"Next-generation sequencing extends the phenotypic spectrum for LCA5 mutations: novel LCA5 mutations in cone dystrophy","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.03.015_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ophtha.2013.08.028","article-title":"Involvement of LCA5 in Leber congenital amaurosis and retinitis pigmentosa in the Spanish population","volume":"121","author":"Corton","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2018.03.015_bib14","first-page":"118","article-title":"Novel human pathological mutations. Gene symbol: LCA5. Disease: Leber congenital amaurosis (LCA)","volume":"127","author":"Vallespin","year":"2010","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2018.03.015_bib15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/humu.22398","article-title":"Screening of a large cohort of leber congenital amaurosis and retinitis pigmentosa patients identifies novel LCA5 mutations and new genotype-phenotype correlations","volume":"34","author":"Mackay","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2018.03.015_bib16","first-page":"1940","article-title":"Identification of a novel LCA5 mutation in a Pakistani family with Leber congenital amaurosis and cataracts","volume":"17","author":"Ahmad","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2018.03.015_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13816810802592567","article-title":"LCA5, a rare genetic cause of leber congenital amaurosis in Koreans","volume":"30","author":"Seong","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2018.03.015_bib18","first-page":"1098","article-title":"Leber congenital amaurosis caused by Lebercilin (LCA5) mutation: retained photoreceptors adjacent to retinal disorganization","volume":"15","author":"Jacobson","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2018.03.015_bib19","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI45627","article-title":"Disruption of intraflagellar protein transport in photoreceptor cilia causes Leber congenital amaurosis in humans and mice","volume":"121","author":"Boldt","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.03.015_bib20","doi-asserted-by":"crossref","first-page":"88ra54","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.03.015_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/hum.2016.111","article-title":"Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina","volume":"28","author":"Ramachandran","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.03.015_bib22","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.03.015_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.16-02-00563.1996","article-title":"Recovery phase of the murine rod photoresponse reconstructed from electroretinographic recordings","volume":"16","author":"Lyubarsky","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.03.015_bib24","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1167\/iovs.04-1427","article-title":"Cone-like morphological, molecular, and electrophysiological features of the photoreceptors of the Nrl knockout mouse","volume":"46","author":"Daniele","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2018.03.015_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1085\/jgp.200409208","article-title":"Photoreceptors of Nrl -\/- mice coexpress functional S- and M-cone opsins having distinct inactivation mechanisms","volume":"125","author":"Nikonov","year":"2005","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.ymthe.2018.03.015_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1085\/jgp.200609490","article-title":"Physiological features of the S- and M-cone photoreceptors of wild-type mice from single-cell recordings","volume":"127","author":"Nikonov","year":"2006","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.ymthe.2018.03.015_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.visres.2010.12.017","article-title":"A mouse M-opsin monochromat: retinal cone photoreceptors have increased M-opsin expression when S-opsin is knocked out","volume":"51","author":"Daniele","year":"2011","journal-title":"Vision Res."},{"key":"10.1016\/j.ymthe.2018.03.015_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/39068","article-title":"Prolonged photoresponses in transgenic mouse rods lacking arrestin","volume":"389","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.03.015_bib29","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1038\/mtm.2014.11","article-title":"Proof of concept for AAV2\/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient","volume":"1","author":"Cereso","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.03.015_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.stem.2016.03.021","article-title":"Identification and correction of mechanisms underlying inherited blindness in human iPSC-derived optic cups","volume":"18","author":"Parfitt","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.03.015_bib31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/hmg\/ddu509","article-title":"Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells","volume":"24","author":"Schwarz","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.03.015_bib32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ymthe.2017.03.008","article-title":"Taking stock of retinal gene therapy: looking back and moving forward","volume":"25","author":"Bennett","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.03.015_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjo.87.4.473","article-title":"Progression of phenotype in Leber\u2019s congenital amaurosis with a mutation at the LCA5 locus","volume":"87","author":"Mohamed","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2018.03.015_bib34","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI57377","article-title":"The human visual cortex responds to gene therapy-mediated recovery of retinal function","volume":"121","author":"Ashtari","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.03.015_bib35","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.03.015_bib36","series-title":"Methods in Molecular Medicine: Ocular Molecular Biology Protocols","first-page":"125","article-title":"Intraocular delivery of recombinant virus","volume":"Volume 47","author":"Liang","year":"2000"},{"key":"10.1016\/j.ymthe.2018.03.015_bib37","doi-asserted-by":"crossref","first-page":"E5574","DOI":"10.1073\/pnas.1414162111","article-title":"Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells","volume":"111","author":"Gaub","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618301242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618301242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:52:47Z","timestamp":1761501167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618301242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1525001618301242"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.015","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}